Overview of This Study:
This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global peptide synthesis market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Major Growth Driving Factors:
Growth in this market is driven by the increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced automated peptide synthesizers. However, the lack of a unified set of regulations for therapeutic peptides and the high cost of instruments are expected to restrain the growth of this market during the forecast period.
COVID-19 impact on the Peptide Synthesis Market
COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic. The COVID-19 pandemic has increased the burden on healthcare systems across the globe. According to the WHO, there were 271,963,258 confirmed cases of COVID-19, including 5,331,019 deaths (as of December 17, 2021). The highest number of deaths was in the Americas, followed by Europe and Southeast Asia.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158927365
Research Methodologies Followed for This Study:
Primary Research:
Extensive primary research was conducted after acquiring basic knowledge about the global peptide synthesis market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CDMOs and CROs, academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners.
These interviews were conducted across four major regions, including North America, Europe, the Asia Pacific, and the Rest of the World. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
Secondary Research:
The secondary sources referred to for this research study include publications from government sources, such as Association of Biomolecular Resource Facilities, Journal of the American Chemical Society, American Peptide Society, Australian Peptide Association, European Peptide Society, Indian Peptide Society, Protein Science Society of Japan (PSSJ), American Peptide Society (APS), National Institutes of Health (NIH), and World Health Organization (WHO). Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global peptide synthesis market, which was validated through primary research.
OPPORTUNITY: Development of personalized medicines
Interest in personalized treatment has been fueled by the concept of tailored therapy with the best response and highest safety margin to ensure better patient care. Proteomic analysis is an attractive and powerful tool for characterizing the molecular profiles of various tissues, either in the normal or diseased state. Personalized proteomics or proteomic profiling is the next big step in personalized medicine; it provides clarity on disease pathomechanisms.
To boost the use of proteomics in personalized medicine, scientists proposed the development of a user-friendly platform to program electrochemically directed peptide synthesis based on a microfluidic multiplexing system controlled by software under the ElectroMed project funded by the European Union. The ligand-receptor complexes will then be detected and quantified by label-free sensors based on nanomaterials.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=158927365
Projected Revenue Surge:
The global peptide synthesis market is projected to USD 730 million by 2026 from USD 515 million in 2021, at a CAGR of 7.2% between 2021 and 2026.
Geographical Growth Dynamics:
North Americawas the largest regional market forPeptide SynthesisMarketin 2020.
The peptide synthesis market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 37.6% of the peptide synthesis market, followed by Europe and the Asia Pacific with shares of 29.8% and 26%, respectively.
The large share of North America in the global market can be attributed to the increasing life science R&D, high prevalence of chronic diseases, increasing investments in the development of structure-based drug designs, growing research in the fields of genomics and proteomics, and increasing focus on developing personalized therapeutics. The US held the largest share of the North American Market in 2020. The large share of the US is primarily attributed to increasing life science research activities in the US and the growing prevalence of cancer and chronic diseases.
No comments:
Post a Comment